These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Survey of Common Aesthetic Practices Among Oculofacial Surgeons in Parts of the Asia-Pacific. Lun KW; Koh V; Wang P; Chiam NP; Sundar G Asia Pac J Ophthalmol (Phila); 2015; 4(5):293-9. PubMed ID: 26288346 [TBL] [Abstract][Full Text] [Related]
7. Natural history of graves' orbitopathy after treatment. Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471 [TBL] [Abstract][Full Text] [Related]
8. [Management of Graves' orbitopathy: evidence-based recommendations]. Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237 [TBL] [Abstract][Full Text] [Related]
9. Survey on the management of orbital and intraocular tumors among oculofacial surgeons in the Asia-Pacific region. Wang PX; Koh VT; Lun K; Sundar G Int Ophthalmol; 2014 Jun; 34(3):723-33. PubMed ID: 24085354 [TBL] [Abstract][Full Text] [Related]
10. 2021 Asia-Pacific Graves' Disease Consortium Survey of Clinical Practice Patterns in the Management of Graves' Disease. Parameswaran R; de Jong MC; Kit JLW; Sek K; Nam TQ; Thang TV; Khue NT; Aye TT; Tun PM; Cole T; Miller JA; Villa M; Khiewvan B; Sirinvaravong S; Sin YL; Muhammad R; Jap TS; Agrawal A; Rajput R; Fernando R; Sumanatilleke M; Suastika K; Shong YK; Lang B; Bartalena L; Yang SP; Endocrine; 2023 Jan; 79(1):135-142. PubMed ID: 36129592 [TBL] [Abstract][Full Text] [Related]
11. The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy. Bartalena L; Kahaly GJ; Baldeschi L; Dayan CM; Eckstein A; Marcocci C; Marinò M; Vaidya B; Wiersinga WM; Eur J Endocrinol; 2021 Aug; 185(4):G43-G67. PubMed ID: 34297684 [TBL] [Abstract][Full Text] [Related]
12. Evaluation and management of Graves' orbitopathy. Lee HB; Rodgers IR; Woog JJ Otolaryngol Clin North Am; 2006 Oct; 39(5):923-42, vi. PubMed ID: 16982255 [TBL] [Abstract][Full Text] [Related]
13. Management of Graves' orbitopathy in Latin America: an international questionnaire study compared with Europe. Ramos HE; Diehl LA; Camacho CP; Perros P; Graf H; Clin Endocrinol (Oxf); 2008 Dec; 69(6):951-6. PubMed ID: 18462263 [TBL] [Abstract][Full Text] [Related]
14. Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves' Orbitopathy (EUGOGO) [Optymalizacja leczenia umiarkowanej do ciężkiej i aktywnej orbitopatii tarczycowej z uwzględnieniem zaleceń European Group on Graves' Orbitopathy (EUGOGO)]. Nowak M; Marek B; Kos-Kudła B; Siemińska L; Londzin-Olesik M; Głogowska-Szeląg J; Nowak W; Kajdaniuk D Endokrynol Pol; 2022; 73(4):756-777. PubMed ID: 36059167 [TBL] [Abstract][Full Text] [Related]
15. Survey of Common Practices among Oculofacial Surgeons in the Asia-Pacific Region: Management of Orbital Floor Blowout Fractures. Koh V; Chiam N; Sundar G Craniomaxillofac Trauma Reconstr; 2014 Sep; 7(3):197-202. PubMed ID: 25136408 [TBL] [Abstract][Full Text] [Related]